Phase 1a studies in healthy volunteers, published in Diabetes, Obesity and Metabolism in 2023, established the compound's single-dose and multiple-dose pharmacokinetics, confirming a half-life supportive of once-daily dosing, a favorable food-effect profile, and dose-proportional exposure across the tested range
A prospective patient may complete intake, pay the program fee, and still be determined medically ineligible
Traditionally, the Beighton score has been used as a quick clinical indicator of joint hypermobility but appropriate sex and age specific cut-offs should be used
Gradual, sustainable weight loss is preferable to rapid reduction
Will stopping GLP-1 medication affect my sex life
Carbohydrate Strategy Carbohydrate intake during recomposition depends on training demands and personal preference